Sensa Neuroscience
1 known investors
Sensa Neuroscience is a drug development company creating SEN126, a CBD-derived analog designed to treat refractory epilepsy, including Developmental and Epileptic Encephalopathies (DEEs). The compound aims to improve on existing therapies like Epidiolex through better pharmacokinetics, reduced liver accumulation, and fewer drug-drug interactions.
Investors · 1
Frequently asked questions
- What does Sensa Neuroscience do?
- Sensa Neuroscience is a drug development company creating SEN126, a CBD-derived analog designed to treat refractory epilepsy, including Developmental and Epileptic Encephalopathies (DEEs). The compound aims to improve on existing therapies like Epidiolex through better pharmacokinetics, reduced liver accumulation, and fewer drug-drug interactions.
- Who are Sensa Neuroscience's investors?
- Sensa Neuroscience's investors include Bonaventure Equity, LLC.